Healthcare - Biotechnology - NASDAQ - US
$ 0.1019
-70 %
$ 29.4 M
Market Cap
-0.15
P/E
BALANCE SHEET
28.8 M
ASSETS
19.8 M
LIABILITIES
9 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Eyenovia, Inc.
| Current Assets | 20.7 M |
| Cash & Short-Term Investments | 14.8 M |
| Receivables | 625 K |
| Other Current Assets | 5.23 M |
| Non-Current Assets | 8.07 M |
| Long-Term Investments | 0 |
| PP&E | 5.04 M |
| Other Non-Current Assets | 3.03 M |
| Current Liabilities | 9.53 M |
| Accounts Payable | 1.75 M |
| Short-Term Debt | 5.83 M |
| Other Current Liabilities | 1.95 M |
| Non-Current Liabilities | 10.2 M |
| Long-Term Debt | 10.2 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Cash & Cash Equivalents | 14.8 | 22.9 | 19.5 | 28.4 | 14.2 | 19.7 | 5.2 | 3.4 | 2.5 |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0.6 | 1.8 | 2.1 | 3.1 | 95.2 K | 0 | 0 | 0 | 0 |
| Inventory | 0.1 | 3.6 | 0 | 1.6 | 95.2 K | 0 | 0 | 0 | 0 |
| Other Current Assets | 5.1 | 3.6 | 0.7 | 2.1 | 0.1 | 0.1 | 37.1 K | 2.34 K | 0.3 |
| Total Current Assets | 20.7 | 27.6 | 22.0 | 33.4 | 14.3 | 19.9 | 5.3 | 3.4 | 2.8 |
| PP&E | 5.0 | 3.3 | 1.3 | 0.4 | 0.2 | 36.7 K | 28 K | 43.2 K | 12.9 K |
| Intangible Assets | 2.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 7.9 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0.9 | 80.9 K | 0.5 | 0.1 | 0.1 | 0.1 | 0.3 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 28.8 | 31.0 | 31.7 | 33.9 | 14.7 | 20.0 | 5.6 | 3.4 | 2.8 |
| LIABILITIES | |||||||||
| Accounts Payable | 1.8 | 1.4 | 1.6 | 1.5 | 1.5 | 1.5 | 0.2 | 0.3 | 0.2 |
| Short Term Debt | 5.8 | 0.8 | 7.2 | 97.5 K | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.9 | 2.3 | 2.4 | 16.6 | 1.3 | 1.6 | 0.3 | 0.1 | 0.2 |
| Total Current Liabilities | 9.5 | 4.5 | 11.2 | 18.2 | 2.9 | 3.1 | 0.6 | 0.4 | 0.4 |
| Long Term Debt | 10.2 | 9.3 | 0 | 0.4 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 19.9 K | 38.7 K | 45.4 K | 41.6 K | 0 | 0 | 0 |
| Total Liabilities | 19.8 | 13.8 | 11.2 | 18.6 | 3.0 | 3.1 | 0.6 | 0.4 | 0.4 |
| EQUITY | |||||||||
| Common Stock | 4.56 K | 3.67 K | 2.84 K | 2.5 K | 1.71 K | 1.15 K | 257 | 227 | 227 |
| Retained Earnings | (145.5) | (118.2) | (90.2) | (77.4) | (57.7) | (36.5) | (19.3) | (14.1) | (10.6) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | 0 | 0 | 0 | 66.1 K | 47 K | 21.6 K | 8.75 K |
| Total Equity | 9.0 | 17.2 | 20.5 | 15.3 | 11.7 | 16.9 | 5.1 | 3.0 | 2.4 |
| Total Liabilities and Equity | 28.8 | 31.0 | 31.7 | 33.9 | 14.7 | 20.0 | 5.6 | 3.4 | 2.8 |
| SHARES OUTSTANDING | |||||||||
| Common Shares Outstanding | 41.0 | 33.6 | 26.3 | 21.1 | 14.3 | 9.5 | 9.9 | 9.9 | 9.9 |